6/13/2011 10:03:24 AM
TAMPA, Fla.--(BUSINESS WIRE)--PanGenex Corporation (“PanGenex” or “the Company”) (Pink Sheets: PGCX), a nutraceutical and dietary supplement developer; today provided the following update to shareholders and other interested parties. First, the Company has invested millions of dollars in developing what it believes are “Best of Breed” products that target soft tissue calcification. The products are more fully described at its website, www.HeartHealthyWorld.com.
comments powered by